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ABSTRACT 
The discovery of a potentially novel proline-specific peptidase from bovine serum is presented 
which is capable of cleaving the dipeptidyl peptidase IV (DPIV) substrate Gly-Pro-MCA. The 
enzyme was isolated and purified with the use of Phenyl Sepharose Hydrophobic Interaction, 
Sephacryl S300 Gel Filtration, and Q-Sephacryl Anion Exchange, producing an overall 
purification factor of 257. SDS PAGE resulted in a monomeric molecular mass of 158 kDa while 
Size Exclusion Chromatography generated a native molecular mass of 328 kDa. The enzyme 
remained active over a broad pH range with a distinct preference for a neutral pH range of 7-8.5. 
Chromatofocusing and Isoelectric Focusing revealed the enzyme’s isoelectric point to be 4.74. 
DPIV-like activity was not inhibited by serine protease inhibitors but was by the metallo-protease 
inhibitors, the phenanthrolines. The enzyme was also partially inhibited by Bestatin. Substrate 
Specificity studies proved that the enzyme is capable of sequential cleavage of bovine β-
Casomorphin and Substance P. The peptidase cleaved the standard DPIV substrate, Gly-Pro-MCA 
with a KM of 38.4 µM, while Lys-Pro-MCA was hydrolysed with a KM of 103 µM. The DPIV-
like activity was specifically inhibited by both Diprotin A and B, non-competitively, generating a 
Ki of 1.4x10-4 M for both inhibitors. Ile-Thiazolidide and Ile-Pyrrolidide both inhibited 
competitively with an inhibition constant of 3.7x10-7 M and 7.5x10-7 M respectively. It is 
concluded that bovine serum DPIV-like activity share many biochemical properties with DPIV 
and DPIV-like enzymes but not exclusively, suggesting that the purified peptidase may play an 
important novel role in bioactive oligopeptide degradation. 
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INTRODUCTION 
 Dipeptidyl Peptidase IV (DPIV) was first reported as glycylproline naphthylamidase in 
rat liver during a commercial preparation of acylase I by Hopsu-Havu and Glenner [1] and has 
been named dipeptidyl aminopeptidase IV (DAPIV) and/or post proline dipeptidyl peptidase 
IV in earlier work [2]. DPIV has been reported to be identical to CD26, the surface marker on T- 
and B-lymphocytes and as an adenosine deaminase (ADA) –binding protein. DPIV is a member 
of the peptidase family S9, which along with prolyl endopeptidase (PEP) and acylaminoacyl 
peptidase form the prolyl oligopeptidase family. It is also the fourth member of the Dipeptidyl 
Peptidase sub-group and has been assigned the enzyme classification number EC 3.4.14.5. 
 The enzyme is ubiquitously distributed and its functionality is varied and numerous. It has 
a dual function as a regulatory protease and as a binding protein. Since its discovery over 35 years 
ago, due to its unique ability to liberate Xaa-Pro or Xaa-Ala dipeptides from the N-terminus of 
regulatory peptides, many more examples are emerging from both in vivo and in vitro studies. The 
specific conformation of the proline residue can impose many structural restrictions on peptides 
and proteins and confer particular biological properties upon a wide range of physiologically 
important biomolecules as well as reducing the potential to protease hydrolysis [3]. DPIV’s 
immunological role has become obvious since its presence on the surface of human peripheral 
lymphocytes was demonstrated [4]. In addition, it is concluded that the T-lymphocyte surface 
antigen, designated CD26 and a leukocyte activation marker (Tp103) were in fact DPIV [5]. 
Dipeptidyl peptidase IV has been widely reported as being expressed in healthy, benign and 
malignant cells. This has led to the enzyme being described as a useful tumour burden marker. 
For example, squamous-cell lung carcinomas showed significantly high DPIV levels [6].  
 Recently, many DPIV-like enzymes have been reported, such as Attractin, Fibroblast 
activation protein α (FAPα) and DP8, displaying DPIV-like activity [7-9], as well as inactive 
proteins [10]. This potentially undermines the many previous reports of the influence of DPIV in 
biological processes and disease states. It is assumed that the effect of DPIV-like enzymes play a 
more important role than was previously considered. Therefore any report of DPIV-like activity 
from various tissues of different species should be treated with added interest.  
Attractin was originally called DPPT-L and thought to be a larger form of DPIV in human 
serum with a molecular monomeric weight of 175 kDa [11]. The protein is expressed and secreted 
by activated T cells and appears to play a significant role in T-cell proliferation. It has also been 
called the Mahogany protein due to its potential in murine colour and obesity mutations as a result 
of its ability to bind to the agouti protein. Although Attractin displayed some CD26 antigenic 
epitopes, the inhibition profiles of both Attractin and DPIV are quite different [12]. In addition, no 
significant sequence homology is shared between the two proteins.    
 FAPα is generally classified as a 95 kDa monomeric serine protease with 49% amino acid 
sequence identity to CD26 [13], however a 175 kDa gelatinase has also been reported as FAP 
[14]. It is expressed as a cell surface antigen with a high expression rate in human malignant 
tumours, suggesting that the enzyme could be a potential marker for tumour invasiveness [8]. 
 Abbott et al., [9] cloned a 882-amino acid protein that has 27% identity and 51% similarity 
to DPIV which they term DPP8. The cloned enzyme has similar biochemical characteristics to 
DPIV such as a 100 kDa monomeric weight but seems to exist as a monomer in the cytoplasm. 
An interesting difference between the two enzymes is that the cloned, recombinant DPP8 enzyme 
is not glycosylated but was still capable of hydrolysis of DPIV substrates, Ala-Pro, Arg-Pro and 
Gly-Pro. 
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 The aim of this study was to isolate and purify, for the first time, a DPIV-like activity from 
bovine serum and characterise its biochemical properties in an effort to distinguish it as 
Dipeptidyl Peptidase IV or one of the DPIV-like enzymes.   
 
MATERIALS AND METHODS 
All peptides and fluorimetric substrates were supplied by Bachem Feinchemikalein AG 
(Bubendorf, Switzerland). All chromatography resins and polybuffers were purchased from 
Pharmacia Fine Chemical Company (Uppsala, Sweden). BCA reagent and Gelcode Blue Protein 
stain were supplied by Pierce Chemical Company (Illinois, USA). A range of tri- and tetra-
peptides were kindly donated by Dr. G. O’Cuinn (National University of Ireland, Galway, 
Ireland). Ile-Thiazolidide and Ile-Pyrrolidide were both kindly donated by Dr. Hans Ullich 
Demuth (Probiodrug, Halle, Germany). All other materials utilised were obtained from Sigma 
Chemical Company (Poole, Dorset, England). 
 
Serum Preparation 
Bovine whole blood was collected from a freshly slaughtered animal and kept in a 4oC cold room 
for 24 hours to allow clot formation. The remaining unclotted blood was then decanted and 
centrifuged at 6,370 x g for 60 mins at 4oC using a Beckman J2-MC refrigerated centrifuge fitted 
with a JL-10.5 rotor. The supernatant and loose cellular debris was decanted and re-centrifuged at 
48,400 x g for 15 mins at 4oC using a JA-20 rotor. The serum was collected, pooled and stored in 
20 ml aliquots at –17oC.  
 
Protein Determination 
Protein concentration was determined by Biuret and BCA (standard and enhanced) assays as 
previously described [15, 16]. BSA was used as the protein standard. Prior to the assay, samples 
were dialysed against 50 mM HEPES, pH 8.0. Absorbances of samples were determined at 570 
nm using a Tecan Spectra Classic photometric plate reader. 
 
Determination of DPIV-like activity 
Dipeptidyl Peptidase IV-like activity was determined by the degradation of 0.1 mM Gly-Pro-
MCA in 1% v/v Ethanol (EtOH) with 50 mM HEPES, pH 8.0 as the diluant. 100 µl of enzyme 
sample was added to 400 µl of thermally equilibrated substrate in triplicate and incubated at 37oC 
for 60 minutes. The reaction was terminated by the addition of 1 ml of 1.5 M acetic acid. Suitable 
negative controls and blanks were included. Liberated MCA was fluorimetrically determined 
using a Perkin-Elmer LS-50 Luminescence Spectrometer at excitation and emission wavelengths 
of 370 and 440 nm, respectively. DPIV-like activity was quantified by reference to an MCA 
standard curve. One unit of enzyme activity is defined as nanomoles of MCA released per minute 
at 37oC. A non-quantitative assay was developed to assist in the rapid detection of Gly-Pro-MCA 
degrading activity in post column chromatography fractions. 200 µl of 0.1 mM Gly-Pro-MCA in 
50 mM HEPES, pH 8.0 was added to 100 µl of sample in each well and the micro-plate was 
incubated at 37oC for 60 minutes. Fluorescence intensities were determined as previously 
described using the Perkin-Elmer LS-50 Luminescence Spectrometer plate reader attachment. 
 
Purification of Gly-Pro-MCA cleaving activity 
 
Phenyl Sepharose hydrophobic interaction chromatography.  
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A 25 ml Phenyl Sepharose CL-4B hydrophobic interaction column (2.5cm x 7cm) was 
equilibrated at 1 ml/min with 100 ml 50 mM HEPES, pH 8.0 containing 5 mM EDTA and 500 
mM ammonium sulphate. Crude serum was thawed at 37oC and solid ammonium sulphate was 
added to a final ammonium sulphate concentration of 500 mM. 5 ml of salted serum was applied 
to the equilibrated column followed by a 100 ml wash of the equilibration buffer to wash through 
any unbound protein. Bound protein was eluted by a 50 ml linear gradient of 50 mM HEPES, pH 
8.0 containing 5 mM EDTA and 500 mM ammonium sulphate to 50 mM HEPES, pH 8.0 
containing 5 mM EDTA.  A further 25 ml wash of 50 mM HEPES, pH 8.0 containing 5 mM 
EDTA ensured all bound protein was eluted. 5 ml fractions were collected and assayed for DPIV-
like activity and protein content as previously described. Fractions containing Gly-Pro-MCA 
degrading activity were combined and the volume recorded to yield post-Phenyl Sepharose DPIV-
like activity and stored at –17oC.  
 
HiPrep 16/10 Sephacryl S-300 HR Gel Filtration Chromatography.  
A 120 ml Hiprep 16/10 Sephacryl S300 High Resolution Gel Filtration column was equilibrated 
at room temperature with 150 ml 50 mM HEPES, pH 8.0 containing 5 mM EDTA at 1 ml/min 
using the Bio-Rad Biologic system and until a steady conductivity and UV baseline was observed. 
The post-Phenyl Sepharose DPIV-like pool was concentrated via reverse dialysis using 
Polyethylene Glycol at 4oC. Glycerol was added to the concentrated sample to generate a final 
glycerol concentration of 10% (v/v). 1.5 ml of concentrated post-Phenyl Sepharose DPIV-like 
activity was loaded onto the column and washed with 150 mM of equilibration buffer at room 
temperature. 3 ml fractions were collected and assayed for DPIV activity and protein content as 
previously described, parallel with online UV monitoring at 280nm. Fractions that contained 
DPIV-like activity were pooled and stored at -17oC.  
 
Q-Sepharose Fast Flow Anion Exchange Chromatography.  
A 20 ml pre-packed Q-Sepharose column attached to a BioRad BioLogic Chromatography system 
was equilibrated with 50 ml 50mM HEPES, pH 8.0 containing 5 mM EDTA. 5 ml of post-
Sephacryl S300 HR DPIV-like activity was applied onto the column followed by a 50 ml wash 
with equilibration buffer. Any bound protein was eluted with a 50 ml linear gradient of 50 mM 
HEPES, pH 8.0 containing 5 mM EDTA to 50 mM HEPES, pH 8.0 containing 5 mM EDTA and 
500 mM NaCl. A further 25 ml wash of 50 mM HEPES, pH 8.0 containing 5 mM EDTA and 500 
mM NaCl ensured that all bound protein was eluted. 3 ml fractions were collected and assayed for 
DPIV activity and protein as previously described, parallel with online UV monitoring at 280nm. 
Fractions that contained DPIV-like activity were pooled and stored.  
 
G100 Gel Filtration Chromatography. 
 A 50 ml G100 Sephadex Gel Filtration column was equilibrated with 100 ml 50 mM HEPES, pH 
8.0 containing 5 mM EDTA. 10 ml of the post QAE pool was applied onto the column and the 
resin was washed with 150 ml 50 mM HEPES, pH 8.0 at 0.5 ml/min containing 5 mM EDTA. 3 
ml fractions were collected and were analysed for Gly-Pro-MCA degrading activity and protein 
content as previously described. The conductivity was measured with a Jenway 4071 
Conductivity Meter which gave an accurate ‘real time’ conductivity reading in units of mS/cm 
which was directly proportional to the salt content. Pooled post G100 fractions typically had 
protein levels of 3 µg/ml (1.5 units/ml) which was concentrated 10-fold before storage at –17oC. 
As a consequence, characterisation studies were performed on 30 µg/ml of purified enzyme unless 
stated otherwise.     
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Assessment of Purity 
SDS-PAGE.  
Samples generated during the purification procedure (serum, post-phenyl Sepharose, post-S300, 
post-QAE and post-G100 DPIV-like) were resolved by electrophoresis under denaturing 
conditions according to the method of Laemmli [17]. Samples were dialysed for 18 hours at 4oC 
against 2 litres of 62.5 mM Tris/HCl, pH 6.8 with buffer changes after 3 and 6 hours. Dialysed 
samples were subsequently diluted in sample solubilization buffer, denatured after a 60 second 
treatment in a boiling water-bath and 10 µg/well was subjected to electrophoresis on a 10% 
acrylamide SDS gel with appropriate High Range molecular weight markers (Sigma). Gels were 
stained as recommended by the Gelcode Reagent protocol (Pierce).     
 
Fluorimetric Analysis.  
Purified DPIV-like activitiy was assayed for the presence of various peptidase activities by 
incubating the enzyme with different specific fluorimetric substrates (Table 2).  Each substrate 
was prepared as a 10 mM stock in 100% v/v EtOH and diluted in 50 mM HEPES, pH 8.0, 
yielding a final concentration of 0.1 mM in 1% v/v Ethanol. 100 µl purified enzyme was 
incubated with 400 µl of each substrate and activity was detected as described previously.  
 
Relative Molecular Mass Determination 
SDS-PAGE:  
The relative molecular weight of the purified DPIV-like enzyme was determined using SDS-
PAGE as previously described. A standard curve of the log of molecular mass versus the relative 
mobility (Rf) of each molecular weight marker was constructed. The log of the molecular mass of 
the purified enzyme was calculated from the calibration curve using its Rf value and its relative 
molecular mass could be estimated. 
 
Size-exclusion FPLC chromatography.  
The enzyme’s relative molecular weight could also be determined with the use of a Hiprep 16/10, 
Sephacryl S-300 (16 x 60mm) size exclusion column on a Bio-Rad Biologic Chromatography 
FPLC system. The column was equilibrated with 200 ml 50 mM HEPES, pH 8.0 with 100 mM 
NaCl. Molecular weight standards or purified enzyme were injected onto the column followed by 
a 200 ml wash with equilibration buffer. The elution volume (Ve) was evaluated via the 
continuous online monitoring at 280 nm. Enzyme elution was determined using the specific 
substrate, Gly-Pro-MCA as previously described. A graph of Ve/Vo versus log molecular weight 
was generated and the native molecular weight of the DPIV-like enzyme determined (where Vo is 
the void volume of the column, estimated using blue dextran).  
 
Optimum pH Determination 
5 ml of purified enzyme was dialysed overnight against 2 litres of distilled water at 4oC. 50 µl of 
dialysate was pre-incubated at 37oC for 15 minutes with 50 µl of a range of 50 mM buffers at 
varying pH values. 100 µM Gly-Pro-MCA was prepared in each of the 50 mM buffers at each pH. 
The effect of the pH and buffer was determined by assaying enzyme activities in triplicate as 
previously outlined. 
 
Isoelectric Point Determination 
Chromatofocusing chromatography. 
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A 25 ml polybuffer exchanger (PBE 94) column was equilibrated with 300 ml 50 mM 
Imidazole/HCl, pH 7.8. Polybuffer 74 was diluted 8-fold in distilled water and the pH adjusted to 
4.5 using HCl. 15 ml of the diluted polybuffer was applied to the column after equilibration. 5 ml 
purified DPIV-like enzyme was dialysed overnight against 3 litres of Imidazole/HCL, pH 7.8 at 
4oC and applied onto the chromatofocusing resin. The resin was washed with 300 ml polybuffer, 
pH 4.5. 3 ml fractions were collected throughout and assayed for DPIV-like activity and their 
pH’s measured.   
 
 
Isoelectric focusing (IEF).  
A vertical pre-cast Isoelectric Focusing (IEF) gel system was employed to determine the 
isoelectric point of the purified enzyme as previously reported [18]. The solution was dialysed 
overnight against 2 litres of 50 mM HEPES, pH 8.0 to remove any IEF contaminants. The 
dialysed sample was diluted with an equal volume of sample buffer. The gels were prepared in an 
ATTO vertical electrophoresis system (160mm x 160mm x 1mm). After the bottom of the 
chamber was filled with 1x anode running buffer, the gels were placed in position and the upper 
chamber filled with cathode buffer. 20 µl of each prepared sample and reconstituted markers were 
loaded into the wells under the cathode buffer. Electrophoresis was carried out at 100V for 60 
min, 200V for the second 60 min and 500V for the final 30 min with the current running from 5-6 
mA/gel. Staining was performed on the gel using brilliant blue G colloidal stain. The stained gel 
image was captured using a UVP white/UV transluminator camera unit driven by Image-Store 
7500 software. A standard curve was constructed of pI versus the Rf for each of the IEF markers. 
The Rf represents the distance migrated by the standard or sample divided by the distance to the 
anoidic lip of the gel. The pI of the enzyme was estimated using the calibration curve by 
calculating its Rf value from the stained gel. 
 
Catalytic Classification 
Functional reagents were prepared in 50 mM HEPES/HCl, pH 8.0 and 50 µl purified DPIV-like 
activity (with the EDTA dialysed out) was pre-incubated in triplicate for 15 min at 37oC with an 
equal volume of each functional reagent concentration (Table 3). After pre-incubation, the 
enzyme and functional reagent were added to 0.1 mM Gly-Pro-MCA and incubated for 60 min at 
37oC. DPIV-like activity was calculated as previously described. 
 
Substrate Specificity 
Reverse-Phase HPLC Analysis 
A range of synthetic and bioactive proline-containing peptides were incubated with 100 µl 
purified enzyme at 37oC for 24 h and the reaction was terminated by the addition of 25 µl 0.5% 
v/v TFA. Blanks, standards and post-incubation samples (20 µl) were applied at 0.5 ml/min to the 
C18 column, equilibrated with 100% buffer A (5% Acetonitrile, 0.2% TFA). After application, the 
column was washed with 4 ml of 100% buffer A, followed by a 10 ml linear gradient of 100% 
buffer A to 100% buffer B (80% Acetonitrile, 0.2% TFA). A 5 ml wash of 100% buffer B eluted 
any remaining hydrophobic peptides. The absorbance of the eluant was continuously monitored 
online at 214nm and 280nm using a diode array detector. 
 
Kinetic Analysis 
KM Determinations  
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The purified enzyme was assayed with increasing concentrations (0-0.5 mM) of Gly-Pro-MCA 
and Lys-Pro-MCA, in triplicate as previously described. The data obtained was applied to 
Michaelis-Menton, Lineweaver-Burk, Eadie-Hofstee and Hanes-Woolf kinetic models. The 
Michaelis-Menton constant, (KM) and the maximum velocity value, (VMax) were subsequently 
determined for both substrates. 
 
KI Determinations 
The inhibition of the purified DPIV-like activity by a variety of peptides was determined. A range 
of Gly-Pro-MCA dilutions (0-1 mM) was prepared and aliquoted (200 µl). An equal volume of 
each peptide concentration was added to the substrate, in triplicate, resulting in a final substrate 
concentration range of 0-0.5 mM. 100 µl of purified enzyme was added to each triplicate and 
blank and incubated at 37oC for 60 min. Enzymatic activity was determined as previously 
described and the resultant data was applied to a number of kinetic models, allowing for the 
estimation of the mode of inhibition and the determination of the inhibition constant (Ki) [19]. 
 
RESULTS 
Purification of the Dipeptidyl Peptidase IV-like activity 
DPIV-like activity was divided into two Gly-Pro-MCA cleaving split peaks after Phenyl 
Sepharose Hydrophobic Interaction chromatography as shown in Figure 1A. The first peak is 
unbound DPIV-like activity while the second peak is bound activity which is eluted at the end of 
the negative Ammonium Sulphate gradient. Interest was focused on the main ‘run-through’ peak 
due to the separation from Z-Gly-Pro-MCA degrading activity such as Prolyl Oligopeptidase 
which is present in the eluted pooled fractions (data not shown). Table 1 shows a 48-fold increase 
in purity of the pooled unbound DPIV-like activity. Further contaminating protein could be 
removed from this enzymatic activity with use of Sephacryl S-300 Gel Filtration Chromatography 
(Fig. 1B.) increasing the purification factor to 74. When using the Q anion exchanger, DPIV-like 
activity bound and eluted sharply on inclusion of 0.5 M sodium chloride as shown in Figure 1C. 
This allowed for a significant removal of contaminating protein (11.5-fold reduction) which 
increased the enzyme’s purity to 250.5-fold. The removal of sodium chloride from the post-QAE 
DPIV-like pool was performed using a G100 Gel Filtration column (Fig. 1D) which also served to 
increase the enzyme’s overall purification factor to 257.3 (Table 1).  
 
Purity Assessment 
SDS PAGE of post column pools visualised numerous protein bands especially for crude serum 
and post-Phenyl Sepharose samples. These bands were considerably reduced after QAE 
Sepharose and one band was observed in the post-G100 pool, at 150 kDa. Contaminating 
peptidase activity in the purified sample was absent, proven by the absence of hydrolysis of a 
range of relevant fluorimetric substrates (Table 2).  
 
Enzyme Characterisation 
SDS-PAGE was also employed to determine the relative molecular mass of the purified enzyme. 
The high molecular weight band observed from the post-G100 sample represented a molecular 
mass of 158 kDa. Size-exclusion FPLC was subsequently employed to evaluate a native 
molecular mass of 328 kDa. As a consequence of these findings, it was deduced that the purified 
peptidase exists as a dimer of similar sized subunits. Chromatofocusing resulted in the elution of 
the Gly-Pro-MCA cleaving activity after a decreasing linear pH gradient, corresponding to an 
elution pool of pH 4.8. Isoelectrofocusing (IEF) of the purified enzyme showed a single band 
with a corresponding pI of 4.74 (Fig. 2). The enzyme showed a distinct optimum at pH 7 - 8.5, 
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with a slight preference for Potassium Phosphate as the buffer (Fig. 3). Despite this, it was 
discovered that the Gly-Pro-MCA substrate autocyclised significantly when formulated in 
Phosphate buffer. Therefore HEPES, pH 8.0 was selected as the buffer of choice.  
Table 3 highlights the effect functional reagents have on the purified enzyme when incubated 
together. The enzyme did not appear to be inhibited by any of the classic serine protease 
inhibitors while the metalloprotease inhibitors had a more potent effect. The metal chelators, 
EDTA and EGTA reduced activity by 19.6 and 18.8% respectively. The phenanthrolines were 
even more inhibitory with 4,7 Phenanthroline reducing the enzyme activity by 46% at 20 mM. 
Certain cysteine protease inhibitors also had an inhibitory effect on the enzyme with 10 mM N-
ethyl maleimide (NEM) reducing activity by approximately 47%. However the classical thiol 
group reducing agent and cysteine protease activator, DTT, had little effect on activity while 
Mercaptoethanol increased activity by 25%. Interestingly, the aminopeptidase inhibitor, Bestatin 
was capable of reducing the enzymatic activity by almost 25%. 
 
Substrate Specificity 
Table 4 outlines the ability of the purified enzyme to hydrolyse synthetic and bioactive peptides, 
detected using reverse-phase HPLC. The enzyme did not seem capable of cleaving any of the β-
amyloid proteins. In general, peptides without a proline at the P1 position were not hydrolysed. 
Interestingly, sequential dipeptide cleavage was achieved for bovine β-Casomorphin (Fig. 4) with 
cleavage products of Tyr-Pro (16.967 min), Phe-Pro (17.833 min) and Gly-Pro (9.9 min). 
Uncleaved β-Casomorphin can be seen as the 18.967 min peak. Similar sequential dipeptide 
cleavage was observed for Substance P (Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2). 
Most peptides containing proline at the penultimate position were cleaved highlighting the 
enzyme’s requirement for the presence of this amino acid.   
 
Kinetic Analysis 
The purified enzyme was investigated further with kinetic studies on standard substrates and 
inhibitors. The KM was estimated using Michealis-Menton, Lineweaver-Burk, Eadie-Hofstee and 
Hanes-Woolf graphical models. The commercial DPIV substrate, Gly-Pro-MCA was hydrolysed 
with an average KM of 38.4 µM. In comparison, Lys-Pro-MCA proved a poor substrate with a KM 
of 102.7 µM (data not shown). When proline containing peptides were included with the Gly-
Pro-MCA substrate, the Michealis-Menten constant was evaluated, the type of possible inhibition 
determined and the resulting Ki estimated. The sequential dipeptide hydrolysis of both β-
Casomorphin and Substance P could be achieved however their inhibition profiles were different. 
β-Casomorphin appears to compete with the substrate for enzyme binding (Table 4). As a 
consequence, a corresponding inhibition constant was estimated as 90 µM. In contrast, Substance 
P appears to inhibit un-competitively with a Ki of 450 µM. Diprotin A and B, two common DPIV 
inhibitors, both had a similar effect on the catalytic properties of the enzyme. Both inhibited non-
competitively with inhibition constants of approximately 140 µM, while the corresponding IC50 
values for both inhibitors were also similar such as 36 µM for Diprotin A (Fig. 5) and 50 µM for 
Diprotin B. Ile-Thiazolidide and Ile-Pyrrolidide proved to be very potent inhibitors of the 
enzymatic activity. Both inhibited competitively with Ile-Thiazolidide having a particularly 
potent effect on the enzyme’s activity with a Ki of 0.37 µM (Table 4).  In addition, Ile-
Thiazolidide also returned a potent IC50 value of 0.75 µM, while a value of 1 µM was discovered 
for Ile-Pyrrolidide (Fig. 6).   
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DISCUSSION 
The serine protease, DPIV has been implicated to influence many biological pathways and 
disorders [13]. However, recent reports of DPIV activity may not be solely attributed to  
Dipeptidyl Peptidase IV [7-9]. As a consequence, Gly-Pro-MCA cleaving activity discovered in 
bovine serum was treated with interest.  Our group has being studying proline specific peptidases 
in bovine brain and therefore were interested to compare these tissue activities to those of serum. 
Hydrophobic Interaction Chromatography separated two DPIV-like activities. The 
unbound peak was re-applied onto the Phenyl Sepharose column under the same conditions to 
investigate the potential of protein overloading of the resin. However, as before, the enzymatic 
activity did not bind to the column indicating that at least two DPIV-like activities are present in 
bovine serum. The Hydrophobic Interaction Chromatography step resulted in separation of the 
main Gly-Pro-MCA cleaving activity from Z-Gly-Pro-MCA cleaving activity attributed to Prolyl 
Oligopeptidase and ZIP which is also present [20]. This was essential as both activities have 
similar substrate specificities. The enzyme was further purified with the use of both gel filtration 
and anion exchange chromatography. The latter column proved particularly successful in 
increasing the purity of the enzyme due to its acidic isoelectric point (pI) resulting in a final 
purification factor of 257. In addition, enzymatic activity was readily detectable allowing for 
accurate characterisation studies to be employed.    
The enzyme’s molecular mass was determined via SDS-PAGE and size exclusion 
chromatography. Under reducing conditions, SDS-PAGE resulted in a monomeric mass of 158 
kDa. The native protein’s molecular mass of 328 kDa indicates that it may exist as a glycosylated 
dimer which correlates well with the postulated structure of DPIV [21].  
The optimum pH for the assay of the purified enzyme was estimated to be in the pH range 
7-8.5 with a typical bell-shaped curve. This range fits perfectly with what has been reported for 
human serum [7, 23]. The inactivation of enzymatic activity at pH’s lower than 6.5, eliminates 
the presence of DPIV-like activity attributed to DPII or Quiescent Cell Proline Dipeptidase (QPP) 
[24-26]. An isoelectric point of 4.74 was determined by Chromatofocusing and Isoelectric 
Focusing which is similar to human lymphocyte DPIV [27] and FAP or Seprase from the cell 
membranes of melanoma cells [14].  
Catalytic classification of the purified enzyme surprisingly resulted in no inhibition from 
the serine protease inhibitors. This deviates from literature which report that DPIV and DPIV-like 
enzymes are ‘unclassical’ serine proteases [13]. However the minimal effect of the classical serine 
protease inhibitor, PMSF, has also been previously reported for human blood DPIV activity [27, 
28]. Interestingly, the metallo protease inhibitors tested had a more potent effect on the enzyme’s 
catalytic activity. The most effective compound, 4,7 phenanthroline, reduced activity by over 
46%. However, the classical metal chelators, EDTA or EGTA did not have such an inhibitory 
effect which correlates with the literature [12]. The cysteine protease inhibitor, NEM had a potent 
effect on reducing the enzyme’s activity. The proposed structure of DPIV outlines a cysteine rich 
region located next to the catalytic domain [21]. Therefore cysteine protease inhibitors and 
activators could ascertain their influence in DPIV or DPIV-like substrate catalysis both positively 
and negatively. However, only 2-mercaptoethanol, the cysteine protease activator, had a slight 
catalytic enhancing effect on the enzyme. This indicates that cysteine is not one of the catalytic 
residues necessary for substrate hydrolysis but may maintain the enzymes active site tertiary 
structure and influence its unique accessibility. A similar effect was observed for DPPT-L or 
Attractin in human serum [12] which further undermines classifying the purified enzyme as a 
serine protease.  
 Substrate specificity via reverse phase HPLC indicated that the enzyme prefers bulky, 
hydrophobic residues but dislikes acidic groups in the P2 position, prefers proline in the P1 
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position and cannot cleave peptides with proline or hydroxyproline in the P1’ position. The most 
interesting result observed was the sequential dipeptide cleavage of the opioid, β-Casomorphin. 
Opioids are polypeptides that influence nerve transmission in certain parts of the brain. They are 
called as such because they bind to specific receptors that bind opiate drugs such as morphine. 
Therefore they may be regarded as the brains own ‘pain killers’ [29]. Bovine β-Casomorphin has 
a proline residue at every second position of the seven amino acid peptide (Tyr-Pro-Phe-Pro-Gly-
Pro-Ile-OH). Therefore it is a perfect candidate for DPIV-like sequential hydrolysis which proved 
to be the case when the three dipeptides were cleaved, namely, Tyr-Pro, Phe-Pro, and Gly-Pro. 
Thus the DPIV-like enzyme could play a role in reducing pain prevention when in the brain. The 
serum enzyme could hydrolyse the peptide, which would subsequently pass the blood-brain 
barrier and have a physiological effect which correlates well with the literature [30]. In addition, 
the peptide’s cleavage was confirmed as solely due to the enzyme when Ile-Pyrrolidide, a specific 
DPIV inhibitor, was added, inhibiting peptide cleavage (data not shown). However, the hydrolysis 
of the third and final dipeptide has been previously reported as difficult or unattainable [31]. 
Therefore, we believe that this is the first report of complete peptide hydrolysis of β-Casomorphin 
by DPIV or a DPIV-like enzyme. Similarly, Substance P is also a perfect candidate for cleavage 
by a DPIV-like enzyme. The eleven amino acid peptide, (Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-
Leu-Met-NH2), contains a proline residue at the second and fourth position at the N-terminus. The 
peptide has many implications, some of which include its release during headache and migrane 
[32]. The purified enzyme was capable of cleaving the two dipeptides which is expected for DPIV 
[30]. The resultant seven amino acid peptide (Gln-Gln-Phe-Phe-Gly-Leu-Met) would have an 
unpredicted but specific effect on receptor binding and response. Nonetheless, the DPIV-like 
enzyme may play an influential role on Substance P effects in vivo. The enzyme’s broad substrate 
specificity and physiological potential is evident from its influence on Enterostatin (Val-Pro-Asp-
Pro-Arg-OH), IGF (Gly-Pro-Glu-) and Neuropeptide Y(1-24) (Tyr-Pro-Ser-Lys-Pro-Asp-Asn-) 
hydrolysis. However the enzymes specificity is directly effected by larger peptides when cleavage 
of the entire Neuropeptide Y molecule was not possible (data not shown). 
 The inclusion of proline containing compounds with the Gly-Pro-MCA substrate had a 
significant effect on the apparent KM obtained. β-Casomorphin inhibited competitively while in 
contrast, Substance P displayed distinct un-competitive inhibition of the enzyme’s activity. The 
difference in the mode of inhibition is interesting as both peptides have a similar sequence with 
the second and fourth amino acid occupied by a proline residue. It is probable that sequential 
cleavage of the peptides is not required to inhibit the enzyme, however the size and the amino 
acid positions play a major role in the mode of inhibition obtained.  
 Inhibitor studies using specific DPIV inhibitors proved that the enzyme can be completely 
inhibited. Diprotin A (Ile-Pro-Ile) and B (Val-Pro-Leu) have been synthesised as specific DPIV 
inhibitors but could also be regarded as good substrates. The hydrophobicity of isoleucine and 
valine at position P2 is preferred by DPIV, competing with the substrate for hydrolysis, creating a 
potent inhibitor. The effect of these compounds both show similar potency resulting in complete 
inhibition but in a non-competitive fashion. Although Diprotin A is most potent in its inhibitory 
capacity, it is expected that both compounds behave in a similar fashion. This correlates well with 
what has been reported for DPIV in the literature [31, 33]. Similarly, Ile-Thiazolidide and Ile-
Pyrrolidide have both been reported as specific DPIV inhibitors, which provides an important tool 
in elucidating the structure and function of the proteolytic enzyme [34]. Both compounds proved 
to be very specific inhibitors of the purified activity. Kinetic analysis of the inhibition showed a 
significantly different mode of inhibition to that of the Diprotins. Both compounds inhibited in a 
competitive manner with Ile-Thiazolidide appearing to be the most potent with a Ki of 0.37 µM. 
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As the structures of both Thiazolidide and Pyrrolidide are almost identical, the only exception 
being the presence of a sulphur atom in the five membered ring of Thiazolidide, it is expected that 
the mode of inhibition is also similar or identical. The inhibition constants reported clearly 
indicate the effect of the compounds on DPIV-like activity and correlates with previous reports 
[34].    
 In summary, we document the first purification and characterisation of DPIV-like activity 
in bovine serum. This peptidase exists as a dimer with a native molecular weight of 328 kDa, 
larger than that reported for DPIV [13] but similar to a large molecular weight protein reported as 
Attractin [22]. In an attempt to further classify this peptidase, the Dipeptidyl aminopeptidase 
activity of the purified enzyme was evaluated with the aminopeptidase inhibitor bestatin where 
25% inhibition was observed which has also been reported for DPIV-like activity thought to be 
attributable to Attractin [22]. Similarily trypsin had no effect on the observed enzymatic activity 
(data not shown) which also correlates with the Attractin report. Another common distinction 
between DPIV and Attractin is the latters inability to bind to ADA [7]. This binding inability was 
also observed for the purified peptidase which suggests that the observed activity is due to 
Attractin. Even though DPIV has been classified as an unclassical serine protease, the purified 
enzyme was resistant to serine protease inhibitors. Enzymatic activity was completely inhibited by 
DPIV specific inhibitors, Diprotin A and B as well as Ile-Thiazolidide and Ile-Pyrrolidide 
indicating that the mode of substrate hydrolysis and inhibition of DPIV and this peptidase are 
similar. Similarly, the enzymatic activity observed was identical to that reported for DPIV with a 
proline residue necessary in the P1 position. The enzyme was capable of sequentially hydrolysing 
β-Casomorphin and Substance P, suggesting a role in pain modulation within the brain. With ever 
increasing reports of DPIV-like activity, it is difficult to comprehensively classify and 
characterise this peptidase. It is interesting to note that while Iwaki-Egawa and co-workers 
reported no enzymatic difference between membrane-bound and serum forms of human DPIV 
[35] Duke-Cohan and co-workers found no sequence homology between them [7].  However, one 
should not rule out the varying effects of enzymes from different species and tissues. These 
effects could involve alternative splicing as well as many unique post-translational modifications. 
Future immunodetection studies, using antibodies raised against bovine DASH molecules, would 
greatly aid in clarifying the exact nature of the relationship between these activities. Nonetheless, 
it is clear that DPIV activity in bovine serum could play a significant role in the degradation and 
turnover of bioactive peptides in the body’s circulatory system and elsewhere. 
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